These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11366775)

  • 1. Why is IL-2 being considered?
    TreatmentUpdate; 1999 Mar; 11(2):2-3. PubMed ID: 11366775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose IL-2 without HAART.
    TreatmentUpdate; 1999 Mar; 11(2):3-4. PubMed ID: 11366776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two years of IL-2 in early HIV disease--fantastic increases in CD4+ cell counts.
    TreatmentUpdate; 1999 Mar; 11(2):4-5. PubMed ID: 11366777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The problem with antivirals alone.
    TreatmentUpdate; 1999 Mar; 11(2):1-2. PubMed ID: 11366774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 (IL-2): a path toward functional eradication?
    Proj Inf Perspect; 1998 Dec; (26):20-1. PubMed ID: 11366494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulation with IL-2 and IL-12.
    Boonprakong L
    STEP Perspect; 1997; 9(1):9-12. PubMed ID: 11364273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals.
    Ghezzi S; Vicenzi E; Soldini L; Tambussi G; Murone M; Lazzarin A; Poli G
    J Biol Regul Homeost Agents; 1997; 11(1-2):74-8. PubMed ID: 9418168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of therapeutic use of interleukin-2 in HIV infection].
    Knysz B; Gasiorowski J; Inglot M; Rymer W; Szymczak A; Gładysz A
    Przegl Epidemiol; 2002; 56(4):587-93. PubMed ID: 12666584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 injections boost CD4 cells.
    AIDS Alert; 1997 Jun; 12(6):69. PubMed ID: 11364361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
    Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
    AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells for sale.
    Whitfield L
    Posit Aware; 1997; 8(6):27-9, 33. PubMed ID: 11364858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
    Beq S; Delfraissy JF; Theze J
    Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent reservoirs of HIV infection: flushing with IL-2?
    Cooper DA; Emery S
    Nat Med; 1999 Jun; 5(6):611-2. PubMed ID: 10371491
    [No Abstract]   [Full Text] [Related]  

  • 16. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients.
    Keh CE; Shen JM; Hahn B; Hallahan CW; Rehm CA; Thaker V; Wynne SM; Davey RT; Lane HC; Sereti I
    AIDS; 2006 Feb; 20(3):361-9. PubMed ID: 16439869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. About interleukin-2.
    Treat Rev; 1995 May; (no 18):6. PubMed ID: 11362594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beating HIV at its own game: the success of IL-2.
    Rochon D
    Res Initiat Treat Action; 1998 Dec; 4(7):15-6. PubMed ID: 11366082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.